FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment
David A. Knorr(Memorial Sloan Kettering Cancer Center), Jeffrey V. Ravetch(Laboratory of Molecular Genetics)
Cited by 31
Related Papers
The role of IgG Fc receptors in antibody-dependent enhancement
|Nature reviews. Immunology|2020|634
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
|Stem Cells Translational Medicine|2013|413
Fcγ Receptor Iib–Deficient Mice Develop Goodpasture's Syndrome upon Immunization with Type IV Collagen
|The Journal of Experimental Medicine|2000|212
FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies
|Proceedings of the National Academy of Sciences|2020|88